GAGNON ROBERT E. (Chief Financial Officer) received a stock award from OPUS GENETICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/11/2025ACC: 0000905148-25-003320
Officer· Chief Financial Officer
Since Sep 2025
+450K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
450K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+200K
Price / share
—
Trade value
—
% of position
New position
9/10/2025
0.00→200K
Total
Net shares
+200K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/10/2025 | A · Award | +200K | — | — | New position | 0.00 | 200K |
| Total | +200K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
250K shares
Shares
+250K
Strike price
1.23
Held after
250K
Exercisable
—
9/2/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock250K shares | 9/2/2025 | A · Award | +250K | 1.23 | — | 250K |